This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Samsung Life Public Welfare Foundation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Na Kyung Lee: Innovator in Stem Cell Therapeutics
Introduction
Na Kyung Lee is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of stem cell research, particularly in enhancing the therapeutic effects of stem cells. Her innovative work has the potential to revolutionize treatments involving stem cell therapies.
Latest Patents
Na Kyung Lee holds a patent titled "Composition for enhancing therapeutic effect of stem cell, comprising immunosuppressant, and method for enhancing therapeutic effect of stem cell using same." This invention relates to a composition designed to improve the survival rate of stem cells by incorporating an immunosuppressant. The composition aims to overcome immune responses associated with the administration of xenogeneic cells, thereby enhancing the stability and efficacy of stem cells. This advancement could lead to the development of mesenchymal stem cell therapeutic agents that maximize the therapeutic effects of stem cells. She has 1 patent to her name.
Career Highlights
Na Kyung Lee is affiliated with the Samsung Life Public Welfare Foundation, where she continues her research and development in the field of stem cell therapy. Her work is characterized by a commitment to improving health outcomes through innovative scientific solutions.
Collaborations
Na Kyung Lee collaborates with notable colleagues, including Jung Won Hwang and Jong Wook Chang. These partnerships enhance her research efforts and contribute to the advancement of stem cell therapies.
Conclusion
Na Kyung Lee is a trailblazer in the field of stem cell therapeutics, with her innovative patent showcasing her dedication to improving medical treatments. Her contributions are poised to make a lasting impact on the future of regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
